SecBot SecBot
SECBOTREPLAY Home › Report › REGN

REGN · Marion McCourt, an officer of Regeneron Pharmaceuticals, filed a Form…

REGENERON PHARMACEUTICALS, INC. · 144 filed Oct 30, 2026 at 16:14 ET

At the news

NEUTRALIMPACT 2/10

144 filed Oct 30, 2026 at 16:14 ET

Marion McCourt, an officer of Regeneron Pharmaceuticals, filed a Form 144 notice of intent to sell 1,132 shares of common stock, valued at approximately $984,195 based on the filing date price. The shares were acquired via restricted stock award vesting in December 2023. This is a routine insider sale notice representing a small fraction of the company's $83.7B market cap.

  • Marion McCourt, an officer of Regeneron, filed Form 144 to sell 1,132 shares of common stock.
  • Estimated sale value is approximately $984,195 based on the filing date price of ~$869 per share.
  • Shares were acquired on 12/12/2023 via restricted stock award vesting from the issuer.
  • The sale is proposed to occur on or after 10/30/2026 on Nasdaq.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access